Lab automation refers to the mechanization or automation of routine tasks in a laboratory. This helps free human researchers from repetitive, labor-intensive tasks and allows them to focus more on complex decision making and advanced analysis. Lab automation involves instruments, devices, and software that enable laboratories to process clinical or research samples automatically with minimal human assistance. Automated systems are used for liquid handling, sample preparation, storage and retrieval, detection, labeling, and other tasks. Advantages of lab automation include increased productivity, reduced human errors, better reproducibility, higher throughput, and lower operational costs. Growing need for higher accuracy and efficiency in clinical testing and research is driving demand for lab automation solutions across various end-user industries like pharmaceutical & biotech companies, hospitals & diagnostic centers, academic & research institutes, and more.

The global Lab Automation Market is estimated to be valued at US$ 4,903.9 million in 2022 and is expected to exhibit a CAGR of 4.9% over the forecast period 2022 to 2030.

Key Takeaways

Key players operating in the lab automation market are Tecan, Thermo Fisher Scientific, PerkinElmer, Danaher, Roche, Siemens, Eppendorf, Beckman Coulter, Hamilton Robotics and BD. The major players are focusing on expanding their product portfolio and new product launches. For instance, in 2022 Thermo Fisher launched several new AI-powered automation systems to advance scientific innovation.


Lab Automation Market Insights  is growing R&D investment in pharmaceutical and biotechnology industries is fueling demand for lab automation systems. Pharma companies are adopting these systems for drug discovery, quality control testing, and clinical trial processes to accelerate research. Additionally, rising complexities in lab testing and increasing workload on laboratory staff is prompting healthcare facilities to automate time-consuming processes.

Technological advancements like inclusion of robotics, artificial intelligence, 3D printing, and IoT in lab automation is making the systems more efficient, precise, and easy-to-use. AI and robotics are enabling automation of complex biological processes and genomics research. 3D printing is utilized for printing biological materials like tissues, organs and peptides, reducing time and costs.

Market Trends

- Modular automation systems are gaining popularity as they offer flexibility to add or remove modules as per workflow needs without replacing the entire system. Their scalable and customizable design suits research organizations and small labs.
- Cloud-based lab automation solutions are a key trend as they allow remote monitoring and management of labs from any location. This enables regulatory compliance, integration of disparate systems, and centralized data management.
- Focus on green labs and sustainable science is prompting increased adoption of automated liquid handling systems for reducing waste, energy, and laboratory space usage. Their advantages pertaining to environmental impact are driving their demand.

Market Opportunities

- Integration of artificial intelligence capabilities into lab automation platforms can make the systems adaptive, automated workflow optimization possible without human intervention. This presents an opportunty for vendors.
- Automation of cell-based assays is an emerging opportunity area as it can expedite drug discovery process and testing applications of regenerative medicine. Increased investments in cell-based research can boost demand.
- Developing economies in Asia Pacific and Latin America present lucrative opportunities for market players owing to increasing healthcare expenditures, pharma industry growth and rising diagnostic infrastructure.

The COVID-19 pandemic has significantly impacted the growth of the lab automation market. Before the pandemic, the market was growing steadily at a CAGR of 4.9% driven by increasing workload in labs, rising need for error-free results, and growing focus on accelerate production. However, during the pandemic there was a surge in demand for lab automation solutions as it helps reduce reliance on human labor and minimizes risk of virus exposure. Many labs and research facilities automated their processes and upgraded existing systems to handle increased testing load for covid detection. This sudden spike in demand boosted market growth in 2020.

However, supply chain disruptions also impacted the market as lockdowns halted production and shipping of new instruments and equipment. Many delayed plans for additional automation. In 2021, as restrictions eased production resumed but disruptions continued with shortage of components. Going forward, to sustain post pandemic growth companies need to focus on strengthening supply chains, increasing local manufacturing, and developing integrated platforms for high-throughput automated testing of multiple analytes. Collaborating with research institutions will also help foster innovation.

In terms of regions, North America holds the largest share of the global lab automation market in terms of value currently. This is attributed to presence of major players, high investments in pharma & biotech R&D, and growing testing volumes in clinical diagnostics and drug discovery domains. The Asia Pacific region is projected to grow the fastest during the forecast period driven by increasing spending on healthcare infrastructure, rising medical tourism, and expanding biopharma industry in countries like China and India.

Get more insights on, Lab Automation Market

Get This Report in Japanese Language: ラボオートメーション市場

Get This Report in Korean Language: 실험실 자동화 시장

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)